Mesa Laboratories Inc(MLAB) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Full metrics table
| Index | RUT | P/E | 143.19 | EPS (ttm) | 0.85 | Insider Own | 4.24% | Shs Outstand | 5.6M | Perf Week | -5.84% |
| Market Cap | 0.68B | Forward P/E | 13.84 | EPS next Y | 15.34% | Insider Trans | -3.02% | Shs Float | 5.4M | Perf Month | 7.29% |
| Enterprise Value | 0.81B | PEG | - | EPS next Q | 1.59 | Inst Own | 90.33% | Short Float | 8.1% | Perf Quarter | 12.73% |
| Income | 0.00B | P/S | 2.71 | EPS this Y | -33.54% | Inst Trans | 2.49% | Short Ratio | 2.36 | Perf Half Y | 55.53% |
| Sales | 0.25B | P/B | 3.59 | EPS next 5Y | - | ROA | 1.12% | Short Interest | 0.43M | Perf YTD | 54.17% |
| Book/sh | 33.73 | P/C | 22.06 | EPS past 3/5Y | 90.85% 13.55% | ROE | 2.66% | 52W High | -8.8% ($132.70) | Perf Year | 91.82% |
| Cash/sh | 5.49 | P/FCF | 12.81 | Sales past 3/5Y | 4.38% 13.22% | ROIC | 1.4% | 52W Low | 105.7% ($58.83) | Perf 3Y | -4.98% |
| Dividend Est. | $0.64 (0.53%) | EV/EBITDA | 17.78 | EPS Y/Y TTM | 842.96% | Gross Margin | 57.35% | Volatility(W/M) | 3.02% 4.41% | Perf 5Y | -54.84% |
| Dividend TTM | 0.64 | EV/Sales | 3.24 | Sales Y/Y TTM | 3.04% | Oper. Margin | 9% | ATR (14) | 4.94 | Perf 10Y | 4.88% |
| Dividend Ex-Date | 2026/8/31 | Quick Ratio | 1.32 | EPS Q/Q | -42.44% | Profit Margin | 1.92% | RSI (14) | 53.33 | Recom | 2.33 |
| Dividend Gr. 3/5Y | - | Current Ratio | 1.79 | Sales Q/Q | 1% | SMA20 | -1.28% ($122.59) | Beta | 1.06 | Target Price | $117.5 |
| Payout | 53.06% | Debt/Eq | 0.85 | Earnings | 2026/8/10 | SMA50 | 10.78% ($109.24) | Rel Volume | 0.68 | Prev Close | $120.91 |
| Employees | 717 | LT Debt/Eq | 0.81 | EPS/Sales Surpr. | 2.1% -1.2% | SMA200 | 26.6% ($95.59) | Avg Volume(3M) | 0.18M | Price | $121.02 |
| IPO | 1984/2/29 | Option/Short | No/Yes | Trades | 3329 | Volume | 124,604 | Change | 0.09% |
Company
MLAB is a Technology sector company, analyzed across 14 metrics on this page including P/E, EPS, dividends, RSI, and MACD.
🔬 Mesa Laboratories (MLAB) is a U.S. life sciences tools company that designs and manufactures quality control, sterilization validation solutions, and precision measurement instruments for regulated industries such as pharmaceuticals, healthcare, and medical devices. With a focus on spore-based sterilization validation, calibration and data logging, and consumables, the company has built a stable demand base tailored to regulated environments.
Over the past 1 year, on the higher side
9% below its 1-year high.
MLAB makes money exceptionally well
Tap to view numbers
Growth has stalled
Earnings are expected to grow by -33.5% this year.
Tap to view numbers
The price looks about right
Trading at 143.2 times earnings.
Tap to view numbers
Results came in about as expected
Slight tendency to beat estimates
Tap to view numbers
Opinions on the outlook are split
Analyst sentiment is Buy.
Tap to view numbers
Holding long would have lost money
Would have changed by -5.0% if bought 5 years ago.
Tap to view numbers
The dividend is on the small side
Pays 0.53% annually in dividends.
Tap to view numbers
Ownership looks stable
Institutions hold 90.3%.
Tap to view numbers
Multiple ETFs hold this stock
Buying this ETF gives you exposure to this stock as well.
KDVD 0.02%
BOUT 0.02%
KNOW 0.02%
AIMS 0.01%
JSML 0.01%It ranks #4 in the industry
Based on market cap of $677M.
MLAB $677M PER 143.2
COHR $60B PER 74.3
KEYS $58B PER 46.6
GRMN $55B PER 29.1
FAQ
What kind of company is MLAB?
MLAB belongs to the Technology sector and operates in the Scientific & Technical Instruments industry.
What is the market cap of MLAB?
The market cap of MLAB is approximately $677M, ranking 2,965 within its sector.
Does MLAB pay dividends?
MLAB has a dividend yield of approximately 0.53%, with an annual dividend of $0.64.
What is the P/E ratio of MLAB?
MLAB has a P/E ratio of approximately 143.2x, which can be used to assess its valuation relative to the Technology sector average.
What is the 52-week high and low for MLAB?
MLAB has recorded a 52-week high of $132.70 and a low of $58.83.
